Generic drugs in oncology – Authors' reply

Charles L. Bennett, Sumimasa Nagai, Y. Tony Yang, Brian K. Chen, Oliver Sartor, James Olen Armitage

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e64
JournalThe Lancet Oncology
Volume18
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Generic Drugs

ASJC Scopus subject areas

  • Oncology

Cite this

Bennett, C. L., Nagai, S., Yang, Y. T., Chen, B. K., Sartor, O., & Armitage, J. O. (2017). Generic drugs in oncology – Authors' reply. The Lancet Oncology, 18(2), e64. https://doi.org/10.1016/S1470-2045(17)30016-5

Generic drugs in oncology – Authors' reply. / Bennett, Charles L.; Nagai, Sumimasa; Yang, Y. Tony; Chen, Brian K.; Sartor, Oliver; Armitage, James Olen.

In: The Lancet Oncology, Vol. 18, No. 2, 01.02.2017, p. e64.

Research output: Contribution to journalLetter

Bennett, CL, Nagai, S, Yang, YT, Chen, BK, Sartor, O & Armitage, JO 2017, 'Generic drugs in oncology – Authors' reply', The Lancet Oncology, vol. 18, no. 2, pp. e64. https://doi.org/10.1016/S1470-2045(17)30016-5
Bennett, Charles L. ; Nagai, Sumimasa ; Yang, Y. Tony ; Chen, Brian K. ; Sartor, Oliver ; Armitage, James Olen. / Generic drugs in oncology – Authors' reply. In: The Lancet Oncology. 2017 ; Vol. 18, No. 2. pp. e64.
@article{725a363856ac40d1bfde358c17baf536,
title = "Generic drugs in oncology – Authors' reply",
author = "Bennett, {Charles L.} and Sumimasa Nagai and Yang, {Y. Tony} and Chen, {Brian K.} and Oliver Sartor and Armitage, {James Olen}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/S1470-2045(17)30016-5",
language = "English (US)",
volume = "18",
pages = "e64",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "2",

}

TY - JOUR

T1 - Generic drugs in oncology – Authors' reply

AU - Bennett, Charles L.

AU - Nagai, Sumimasa

AU - Yang, Y. Tony

AU - Chen, Brian K.

AU - Sartor, Oliver

AU - Armitage, James Olen

PY - 2017/2/1

Y1 - 2017/2/1

UR - http://www.scopus.com/inward/record.url?scp=85011846098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011846098&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(17)30016-5

DO - 10.1016/S1470-2045(17)30016-5

M3 - Letter

C2 - 28214418

AN - SCOPUS:85011846098

VL - 18

SP - e64

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 2

ER -